BioCentury
ARTICLE | Clinical News

Bio-Technology General regulatory update

September 7, 1993 7:00 AM UTC

South Korea gave its approval for sale of BTGC's BioLon, a syringe containing a sodium hyaluronate solution for use in ophthalmic procedures. BioLon is being sold in Canada, Greece, Israel and Spain. ...